Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) are potent immunomodulators influencing T cells and NK cells.
• Exosomes, secreted by MSCs, are potential mediators of their therapeutic effects.
• Understanding exosome-mediated regulation is crucial for developing novel immunotherapies.

Purpose of the Study:

• To investigate the role of fetal liver (FL) MSC-derived exosomes in regulating natural killer (NK) cell function.
• To identify the specific molecular mechanisms by which these exosomes exert their immunomodulatory effects on NK cells.

Main Methods:

• Isolation and characterization of exosomes derived from FL-MSCs.
• Co-culture of NK cells with FL-MSC-derived exosomes.
• Analysis of NK cell proliferation, activation, and cytotoxicity.
• Investigation of TGFβ signaling pathway activation (Smad2/3) in NK cells.
• Use of neutralizing anti-TGFβ antibody to block exosome-mediated inhibition.

Main Results:

• FL-MSC-derived exosomes significantly inhibited NK cell proliferation, activation, and cytotoxicity.
• Exosomes were found to carry latency-associated peptide (LAP), TGFβ, and thrombospondin 1 (TSP1).
• Exosomes induced TGFβ/Smad2/3 signaling in NK cells.
• Neutralization of TGFβ reversed the inhibitory effects of exosomes on NK cell functions.

Conclusions:

• FL-MSC-derived exosomes regulate NK cell functions primarily through exosome-associated TGFβ.
• TGFβ signaling is the key pathway mediating the immunomodulatory effects of these exosomes on NK cells.
• FL-MSC-derived exosomes represent a promising cell-free therapeutic strategy for modulating NK cell activity in allogeneic settings.